Search clinical trials for: Abraxane®
Total 14124 results
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnOvarian Cancer | Endometrial Cancer | Recurrent Endometrial Cancer | Recurrent Ovarian Cancer
-
CelgeneCompletedColorectal NeoplasmsFrance
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Washington University School of MedicineCompletedCarcinoma, Non-Small-Cell LungUnited States
-
CelgeneCompletedNon-Small Cell Lung CarcinomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Comprehensive Cancer NetworkCompletedSolid Tumors | Liver Cancer | Advanced CancersUnited States
-
Herlev HospitalCelgeneCompletedUnresectable Pancreatic CarcinomaDenmark, Norway
-
Institut de Recherches Internationales ServierTerminatedLymphoma | Advanced Solid TumorsUnited States, Spain, France
-
CelgeneCompleted
-
CelgeneCompleted
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Herlev HospitalRecruitingBorderline Resectable, Locally Advanced or Metastatic Pancreatic CancerDenmark
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Squamous Cell, Non-small-cell LungPoland, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Japan, Mexico, New Zealand, Romania, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Nektar TherapeuticsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Spain, Australia, France
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non-Small Cell Lung CancerPoland, United States, Argentina, Austria, Brazil, Chile, China, Colombia, France, Germany, Israel, Japan, Korea, Republic of, Mexico, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
CelgeneTerminatedHemodialysis Graft DysfunctionUnited States
-
Incyte CorporationCompletedPancreatic Cancer | Solid TumorsUnited States
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Kaiser PermanenteCelgene CorporationCompletedProstate CancerUnited States
-
Southeastern Gynecologic OncologyCelgene CorporationCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Orinove, Inc.Active, not recruitingMetastatic Breast Cancer | Advanced Solid TumorUnited States
-
Genta IncorporatedUnknown
-
Merck Sharp & Dohme LLCRecruiting
-
West Virginia UniversityOrtho Biotech, Inc.CompletedMetastatic Breast CancerUnited States
-
Gruppo Oncologico Italiano di Ricerca ClinicaIstituto Toscano Tumori; Temas srl; Clirest s.r.l.; Mipharm S.p.A.UnknownSmall Cell Lung CancerItaly
-
Massachusetts General HospitalIpsenRecruitingEsophagogastric Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Celgene CorporationCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Celgene CorporationTerminated
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
First People's Hospital of HangzhouUnknownCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous CellChina
-
Processa PharmaceuticalsCompletedMetastatic Pancreatic CancerUnited States
-
Fudan UniversityCompleted
-
Zhejiang Cancer HospitalUnknown
-
Harold J. Burstein, MD, PhDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Celgene...Completed
-
Mt. Sinai Medical Center, MiamiCelgene CorporationCompletedColorectal CancerUnited States
-
Celgene CorporationCompleted
-
Incyte CorporationTerminatedBreast Cancer | Pancreatic Cancer | Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Advanced Cancer | NHL (Non-Hodgkin Lymphoma) | UC (Ureter and Urethera)United States
-
Fujian Medical University Union HospitalNot yet recruitingImmunotherapy;Envafolimab; Esophageal Cancer
-
Tianjin Medical UniversityUnknown
-
Washington University School of MedicineTerminatedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted